Cargando…
The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test
Background: Dysfunction of the cholinergic system is associated with the development of Alzheimer’s disease (AD). One of the new possible strategies for the pharmacological modulation of memory-related problems typical of AD, is connected with the endocannabinoid system (ECS) and the cannabinoid (CB...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268103/ https://www.ncbi.nlm.nih.gov/pubmed/35807499 http://dx.doi.org/10.3390/molecules27134252 |
_version_ | 1784743897956614144 |
---|---|
author | Kruk-Slomka, Marta Dzik, Agnieszka Biala, Grazyna |
author_facet | Kruk-Slomka, Marta Dzik, Agnieszka Biala, Grazyna |
author_sort | Kruk-Slomka, Marta |
collection | PubMed |
description | Background: Dysfunction of the cholinergic system is associated with the development of Alzheimer’s disease (AD). One of the new possible strategies for the pharmacological modulation of memory-related problems typical of AD, is connected with the endocannabinoid system (ECS) and the cannabinoid (CB: CB1 and CB2) receptors. Methods: The aim of the study was to determine the influence of the selective CB2 receptor ligands: agonist (JWH 133) and antagonist (AM 630) on different stages of memory and learning in mice, in the context of their interaction with cholinergic pathways. To assess and understand the memory-related effects in mice we used the passive avoidance (PA) test. Results: We revealed that co-administration of non-effective dose of JWH 133 (0.25 mg) or AM 630 (0.25 mg/kg) with the non-effective dose of cholinergic receptor agonist - nicotine (0.05 mg/kg) enhanced cognition in the PA test in mice; however, an acute injection of JWH 133 (0.25 mg/kg) or AM 630 (0.25 mg/kg) had no influence on memory enhancement induced by the effective dose of nicotine (0.1 mg/kg). Co-administration of JWH 133 (0.25 mg) or AM 630 (0.25 mg/kg) with the effective dose of the cholinergic receptor antagonist scopolamine (1 mg/kg) attenuated the scopolamine-induced memory impairment in the PA test in mice. Conclusion: Our experiments have shown that CB2 receptors participate in the modulation of memory-related responses, especially those in which cholinergic pathways are implicated. |
format | Online Article Text |
id | pubmed-9268103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92681032022-07-09 The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test Kruk-Slomka, Marta Dzik, Agnieszka Biala, Grazyna Molecules Article Background: Dysfunction of the cholinergic system is associated with the development of Alzheimer’s disease (AD). One of the new possible strategies for the pharmacological modulation of memory-related problems typical of AD, is connected with the endocannabinoid system (ECS) and the cannabinoid (CB: CB1 and CB2) receptors. Methods: The aim of the study was to determine the influence of the selective CB2 receptor ligands: agonist (JWH 133) and antagonist (AM 630) on different stages of memory and learning in mice, in the context of their interaction with cholinergic pathways. To assess and understand the memory-related effects in mice we used the passive avoidance (PA) test. Results: We revealed that co-administration of non-effective dose of JWH 133 (0.25 mg) or AM 630 (0.25 mg/kg) with the non-effective dose of cholinergic receptor agonist - nicotine (0.05 mg/kg) enhanced cognition in the PA test in mice; however, an acute injection of JWH 133 (0.25 mg/kg) or AM 630 (0.25 mg/kg) had no influence on memory enhancement induced by the effective dose of nicotine (0.1 mg/kg). Co-administration of JWH 133 (0.25 mg) or AM 630 (0.25 mg/kg) with the effective dose of the cholinergic receptor antagonist scopolamine (1 mg/kg) attenuated the scopolamine-induced memory impairment in the PA test in mice. Conclusion: Our experiments have shown that CB2 receptors participate in the modulation of memory-related responses, especially those in which cholinergic pathways are implicated. MDPI 2022-07-01 /pmc/articles/PMC9268103/ /pubmed/35807499 http://dx.doi.org/10.3390/molecules27134252 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kruk-Slomka, Marta Dzik, Agnieszka Biala, Grazyna The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test |
title | The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test |
title_full | The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test |
title_fullStr | The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test |
title_full_unstemmed | The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test |
title_short | The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test |
title_sort | influence of cb2-receptor ligands on the memory-related responses in connection with cholinergic pathways in mice in the passive avoidance test |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268103/ https://www.ncbi.nlm.nih.gov/pubmed/35807499 http://dx.doi.org/10.3390/molecules27134252 |
work_keys_str_mv | AT krukslomkamarta theinfluenceofcb2receptorligandsonthememoryrelatedresponsesinconnectionwithcholinergicpathwaysinmiceinthepassiveavoidancetest AT dzikagnieszka theinfluenceofcb2receptorligandsonthememoryrelatedresponsesinconnectionwithcholinergicpathwaysinmiceinthepassiveavoidancetest AT bialagrazyna theinfluenceofcb2receptorligandsonthememoryrelatedresponsesinconnectionwithcholinergicpathwaysinmiceinthepassiveavoidancetest AT krukslomkamarta influenceofcb2receptorligandsonthememoryrelatedresponsesinconnectionwithcholinergicpathwaysinmiceinthepassiveavoidancetest AT dzikagnieszka influenceofcb2receptorligandsonthememoryrelatedresponsesinconnectionwithcholinergicpathwaysinmiceinthepassiveavoidancetest AT bialagrazyna influenceofcb2receptorligandsonthememoryrelatedresponsesinconnectionwithcholinergicpathwaysinmiceinthepassiveavoidancetest |